Basic Info.
Product Description
Amanlac-lta
strains contained :
- lactobacillus acidophilus
- lactobacillus plantarum
- bifidobacterium longum
- bifidobacterium lactis(animalis)
- streptococcus thermophilus
- enterococcus faecium
- k-lac(patent) : lactic acid bacteria prevention and treating allergic diseases / lactobacillus plantarum k8 preventing atherosclerosis by inhibiting absorption of cholesterol and improving the profile of lipid in blood
prebiotics :
- fructo oligosaccharide
- lactulose
viable cell counts :
2.0x109cfu/g(initial) ~ 5.0x107cfu/g(shelf life)
form :
60sachet/box
ingestion :
2sachet/day
shelf life : 18month
Company Profile
|
Business Type: |
Ambio, venture company foundation based on marine biotech, was found in busan 2007 which is the center of marine business. currently ambio has its main business in probiotics and micro-algae. ambio has their factory and r&d center in jinju, and has their sales department in seoul.
in the year 2010, ambio has succeed in developing the membrane cell bioreactor cultivation technology which can cultivate 1 trillion live cells of lactic acid bacteria per gram. by this, ambio have achieved new excellent technology(net) and health technology(ht) certificate from the korean government by developing this technology. ambio is currently supplying their bulk products to the domestic and to the oversea market actively. ambio is also spreading their business to the finished products. ambio has achieved the gmp certificate in the early 2011, and they are supplying the products by strict quality basis.
for the long-term plan, ambio has vision for developing and supplying various materials from marine biotechnology. ambio will do their best for the coming future. |
|
Comapany: |
Ambio co., ltd. |
|
Address: |
No.203, jung gok building, bangwha- |
|
City: |
Seoul |
|
Zip/Postal: |
157-846 |
|
State: |
Kyungki-do |
|
Country: |
Korea |
.